New Drugs in Pharmacy Practice
Continuing Education Newsletter
The Drug Information Center at the KU School of Pharmacy offers a newsletter with monographs of recently FDA approved drugs. The newsletter will allow for pharmacists to learn about new products available on the market and where they fit into current practice. A new issue will be published every 3 months.
The newsletter has been approved by the Kansas State Board of Pharmacy as a CE activity. After reading the newsletter, the participant may receive 1.5 hours of CE (0.15 CEUs) upon scoring 80% or higher on the online post-test through December 31, 2017. The CE certificate will be available to print for submission to the Kansas State Board of Pharmacy. You must submit the certificate to the KBOP within 30 days of completing the activity in order to receive CE credit. Note that this is not an ACPE accredited CE activity; therefore, the CE will not be included in the NABP CE monitor.
You may go to www.dic.ku.edu/login to access the post-test online. First time users will have to register with your name and additional information. Your personal information entered on the website are required information that the DIC must have on le inn order to comply with the State Board of Pharmacy requirements as a CE provider. Your personal information will not be shared with third parties.
Exondys 51, Byvalson, and Zinplava